Dr. Vinayak Aggarwal
Senior Director
30 years of experienceCardiothoracic and Vascular Surgeons
MBBS, MD, DNB, FASE, FACC, FAHA
Fortis Memorial Research Institute (FMRI), Gurgaon
Max Institute of Cancer Care, Lajpat Nagar, New Delhi
Book an AppointmentAbout Dr. Vinayak Aggarwal
Dr. Vinayak Agrawal is a widely experienced Cardiothoracic Surgeon with more than 30 years of expertise. He did his MBBS from Maulana Azad Medical Collegein 1994. After that, he di MD ( Internal Medicine ) from Univ. Coll. of Medical Sciences, in 1998. He also did a DNB ( Cardiology) from Fortis Escorts Heart Inst., in 2004. Dr. Aggarwal has Fellowship of American Coll. of Cardiology (FACC), Fellowship of American Society of Echocardiography (FASE), and Fellowship of American Heart Failure Association (FAHA). He is known for providing compassionate care to his patients. He is a well-known part of various reputed organizations such as Cardiological Society Of India (CSI), American Society Of Echocardiography (ASE), and Indian Academy Of Echocardiography. He has numerous publications under his credit.Education
MBBS, Maulana Azad Medical Coll., 1994 MD ( Internal Medicine ) from Univ. Coll. of Medical Sciences. 1998 DNB ( Cardiology )Fortis Escorts Heart Inst., 2004 a fellow of American Society of Echocardiography (FASE), 2013 Fellowship of American Coll. of Cardiology (FACC), 2014 a fellow of American Heart Failure Association (FAHA)Training & Certificates
advanced training in Internal medicine he also acquired nearly 1 years of professional experience in the field of Neurology after his MD medicinePast Experience
Director & Head (Clinical Cardiology and Cardiac Imaging), Pushpawati Singhania Research Inst. (PSRI), Saket, 2021 Associate Director (Cardiology), Medanta, The Medicity, Gurguram, 2019 Consultant (Cardiology), Indraprastha Apollo Hosp., New Delhi, 2009 Consultant (Cardiology) at Escorts Heart Inst. and Research centre New Delhi, 2007Associations/Membership
Cardiological Society Of India (CSI). American Society Of Echocardiography (ASE). Indian Academy Of Echocardiography. Fellowship of American Coll. of Cardiology (FACC) a fellow of American Society of Echocardiography (FASE) a fellow of American Heart Failure Association (FAHA)
Paper Published
Renal and vascular complications of diabetes. Vishal Saxena, Vinayak Agarwal, Vijay Kher. Chapter 4. Renal Function in Hypertension and Diabetes. 2013; in press. Echocardiographic assessment of intra-cardiac masses. Vinayak Agrawal. Journal Indian Academy of Echocardiography. 2010; 22: (2): 109-117. Requirement of pharmacological treatment for primary prevention of cardiovascular disease in asymptomatic office-executives in north-India. Kasliwal RR, Bansal M, Mehrotra R, Agrawal V, Shrivastava S. Indian Heart J. 2010 Jul-Aug; 62(4):324-9. Isolated Systolic Hypertension. Supplement on hypertension. Vinayak Agrawal, Ravi R Kasliwal. Indian Heart Journal, Mar 2010. Thrombolyis versus primary percutaneous intervention in ST-elevation myocardial infarction: evidence versus clinical practice. ECAB clinical update. (Elsevier). Vinayak Agrawal, Ravi R Kasliwal. Cardiology, 2009. Primary tumor of the heart. Angiosarcoma. Bansal M, Mehrotra R, Agrawal V, Kasliwal RR, Trehan N. Indian Heart J. Jul-Aug 2009; 61(4):383. Time-trends in prevalence and awareness of cardiovascular risk factors in an asymptomatic North Indian urban population. Bansal M, Shrivastava S, Mehrotra R, Agrawal V, Kasliwal RR. J Assoc Physicians India. Aug 2009; 57: 568-73. Mitral valve assessment using real time three-dimensional transesophageal echocardiography. Rahul Mehrotra, Manish Bansal, Vinayak Agarwal, Ravi R Kasliwal. Indian Heart Journal. 2009; 61:123-25. Clinical profile of epilepsy in a tertiary care centre. Kiran Bala, V Agrawal, P Mittal, A Prasad, MM Singh. Neurocon. 1999. Angiotensin II receptor blockers: current perspective. Agrawal V, Manohar G, Kasliwal RR. JAPI. 2003; 51: 706-713. \Permanent atrial fibrillation outcome study using dronedarone on top of standard therapy (PALLAS). Sponsor – Sanofi Aventis. [Co-investigator]. The Stabilization of plaques using darapladib-thrombolysis in myocardial infarction 52 trial (SOLID-TIMI 52). Sponsor – GlaxoSmithKline. [Co-investigator]. Phase III trial (the AKKA study) with eprotirome in the heterozygous familial hypercholesterolemia (HeFH) patients. (prematurely terminated, Oct 2011). Sponsor – Karo Bio. [Co-investigator]. IMPROVE–IT examining outcomes in subjects with acute coronary syndrome:vytorin (ezetimibe/simvastatin) vs simvastatin. Sponsor – Merck. [Co-investigator]. MIRACLE –EF study. Sponsor – Medtronic. [Co-investigator].
Area of Expertise
- 24-Hour Holter Monitoring
- 64-Slice CT Angiography
- Ablation Therapy
- Ambulatory BP Monitoring (ABPM)
- Aneurysm Surgery: Traditional Open Surgery
- Angiography